Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | nuclear factor, erythroid 2-like 2 | Starlite/ChEMBL | No references |
Homo sapiens | SMAD family member 2 | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Loa Loa (eye worm) | MH2 domain-containing protein | Get druggable targets OG5_131716 | All targets in OG5_131716 |
Loa Loa (eye worm) | transcription factor SMAD2 | Get druggable targets OG5_131716 | All targets in OG5_131716 |
Brugia malayi | MH2 domain containing protein | Get druggable targets OG5_131716 | All targets in OG5_131716 |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | MH2 domain containing protein | SMAD family member 2 | 467 aa | 405 aa | 31.6 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | pyruvate dehydrogenase E1 component beta subunit, putative | 0.0077 | 0.4479 | 0.4395 |
Trypanosoma brucei | pyruvate dehydrogenase E1 beta subunit, putative | 0.0077 | 0.4479 | 1 |
Toxoplasma gondii | pyruvate dehydrogenase complex subunit PD-HE1Beta | 0.0077 | 0.4479 | 1 |
Trypanosoma cruzi | pyruvate dehydrogenase E1 beta subunit, putative | 0.0077 | 0.4479 | 1 |
Mycobacterium tuberculosis | Probable 1-deoxy-D-xylulose 5-phosphate synthase Dxs1 (1-deoxyxylulose-5-phosphate synthase) (DXP synthase) (DXPS) | 0.0054 | 0.2543 | 0.5 |
Schistosoma mansoni | transketolase | 0.0054 | 0.2543 | 0.5529 |
Leishmania major | transketolase | 0.0054 | 0.2543 | 0.5529 |
Chlamydia trachomatis | oxoisovalerate dehydrogenase subunits alpha/beta | 0.0061 | 0.3087 | 0.6787 |
Trypanosoma brucei | chrX additional, unordered contigs | 0.0054 | 0.2543 | 0.5529 |
Toxoplasma gondii | pyruvate dehydrogenase E1 component, beta subunit, putative | 0.0054 | 0.2543 | 0.5529 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.0043 | 0.1661 | 0.3493 |
Loa Loa (eye worm) | 2-oxoglutarate dehydrogenase E1 component | 0.0025 | 0.0149 | 0.0149 |
Echinococcus multilocularis | pyruvate dehydrogenase | 0.0077 | 0.4479 | 1 |
Entamoeba histolytica | transketolase, putative | 0.0054 | 0.2543 | 1 |
Mycobacterium ulcerans | 1-deoxy-D-xylulose-5-phosphate synthase | 0.0054 | 0.2543 | 1 |
Leishmania major | 2-oxoisovalerate dehydrogenase beta subunit, mitochondrial precursor, putative | 0.0054 | 0.2543 | 0.5529 |
Mycobacterium ulcerans | transketolase | 0.0054 | 0.2543 | 1 |
Brugia malayi | pyruvate dehydrogenase E1 component beta subunit, mitochondrial | 0.0077 | 0.4479 | 0.4395 |
Brugia malayi | 2-oxoisovalerate dehydrogenase beta subunit, mitochondrial precursor | 0.0054 | 0.2543 | 0.243 |
Echinococcus multilocularis | transketolase | 0.0054 | 0.2543 | 0.5529 |
Trypanosoma brucei | 2-oxoisovalerate dehydrogenase beta subunit, mitochondrial precursor, putative | 0.0054 | 0.2543 | 0.5529 |
Echinococcus granulosus | pyruvate dehydrogenase | 0.0077 | 0.4479 | 1 |
Plasmodium vivax | 1-deoxy-D-xylulose 5-phosphate synthase, putative | 0.0054 | 0.2543 | 0.5529 |
Schistosoma mansoni | hypothetical protein | 0.0043 | 0.1661 | 0.3493 |
Echinococcus multilocularis | transketolase | 0.0054 | 0.2543 | 0.5529 |
Trypanosoma cruzi | 2-oxoisovalerate dehydrogenase beta subunit, mitochondrial precursor, putative | 0.0054 | 0.2543 | 0.5529 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0144 | 1 | 1 |
Mycobacterium tuberculosis | Transketolase Tkt (TK) | 0.0054 | 0.2543 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0054 | 0.2543 | 0.2543 |
Plasmodium vivax | pyruvate dehydrogenase E1 component subunit beta, putative | 0.0077 | 0.4479 | 1 |
Trypanosoma cruzi | transketolase, putative | 0.0054 | 0.2543 | 0.5529 |
Echinococcus granulosus | transketolase | 0.0054 | 0.2543 | 0.5529 |
Chlamydia trachomatis | 1-deoxy-D-xylulose-5-phosphate synthase | 0.0054 | 0.2543 | 0.5529 |
Trypanosoma cruzi | pyruvate dehydrogenase E1 beta subunit, putative | 0.0077 | 0.4479 | 1 |
Entamoeba histolytica | transketolase, putative | 0.0054 | 0.2543 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0077 | 0.4479 | 0.4479 |
Plasmodium falciparum | pyruvate dehydrogenase E1 component subunit beta | 0.0077 | 0.4479 | 1 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.0043 | 0.1661 | 0.3493 |
Trypanosoma cruzi | transketolase, putative | 0.0054 | 0.2543 | 0.5529 |
Treponema pallidum | 1-deoxy-D-xylulose-5-phosphate synthase | 0.0054 | 0.2543 | 0.5 |
Echinococcus granulosus | transketolase | 0.0054 | 0.2543 | 0.5529 |
Trypanosoma cruzi | 2-oxoisovalerate dehydrogenase beta subunit, mitochondrial precursor, putative | 0.0054 | 0.2543 | 0.5529 |
Brugia malayi | hypothetical protein | 0.0043 | 0.1661 | 0.1535 |
Mycobacterium leprae | PROBABLE 1-DEOXY-D-XYLULOSE 5-PHOSPHATE SYNTHASE DXS1 (1-DEOXYXYLULOSE-5-PHOSPHATE SYNTHASE) (DXP SYNTHASE) (DXPS) | 0.0054 | 0.2543 | 1 |
Toxoplasma gondii | 1-deoxy-D-xylulose-5-phosphate synthase | 0.0054 | 0.2543 | 0.5529 |
Plasmodium falciparum | 2-oxoisovalerate dehydrogenase subunit beta, mitochondrial, putative | 0.0054 | 0.2543 | 0.5529 |
Schistosoma mansoni | transketolase | 0.0054 | 0.2543 | 0.5529 |
Leishmania major | pyruvate dehydrogenase E1 beta subunit, putative | 0.0077 | 0.4479 | 1 |
Entamoeba histolytica | transketolase, putative | 0.0054 | 0.2543 | 1 |
Trypanosoma brucei | transketolase, putative | 0.0054 | 0.2543 | 0.5529 |
Loa Loa (eye worm) | 2-oxoisovalerate dehydrogenase subunit beta | 0.0054 | 0.2543 | 0.2543 |
Chlamydia trachomatis | transketolase | 0.0054 | 0.2543 | 0.5529 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.0043 | 0.1661 | 0.3493 |
Toxoplasma gondii | transketolase | 0.0054 | 0.2543 | 0.5529 |
Mycobacterium tuberculosis | Probable branched-chain keto acid dehydrogenase E1 component, beta subunit BkdB | 0.0054 | 0.2543 | 0.5 |
Wolbachia endosymbiont of Brugia malayi | transketolase | 0.0054 | 0.2543 | 0.5529 |
Schistosoma mansoni | pyruvate dehydrogenase (lipoamide) | 0.0077 | 0.4479 | 1 |
Mycobacterium leprae | Probable transketolase Tkt (TK) | 0.0054 | 0.2543 | 1 |
Brugia malayi | transketolase | 0.0054 | 0.2543 | 0.243 |
Chlamydia trachomatis | pyruvate dehydrogenase subunit beta | 0.0077 | 0.4479 | 1 |
Mycobacterium ulcerans | pyruvate dehydrogenase E1 component subunit PdhB | 0.0054 | 0.2543 | 1 |
Entamoeba histolytica | transketolase, chloroplast, putative | 0.0054 | 0.2543 | 1 |
Plasmodium vivax | 2-oxoisovalerate dehydrogenase subunit beta, mitochondrial, putative | 0.0054 | 0.2543 | 0.5529 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0144 | 1 | 1 |
Plasmodium falciparum | 1-deoxy-D-xylulose 5-phosphate synthase | 0.0054 | 0.2543 | 0.5529 |
Loa Loa (eye worm) | hypothetical protein | 0.0077 | 0.4479 | 0.4479 |
Trichomonas vaginalis | transketolase, putative | 0.0054 | 0.2543 | 0.5 |
Trypanosoma brucei | 2-oxoisovalerate dehydrogenase beta subunit, mitochondrial precursor, putative | 0.0054 | 0.2543 | 0.5529 |
Wolbachia endosymbiont of Brugia malayi | pyruvate dehydrogenase subunit beta | 0.0077 | 0.4479 | 1 |
Onchocerca volvulus | 0.0059 | 0.2938 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 4.4668 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860] | ChEMBL. | No reference |
Potency (functional) | 18.3564 uM | PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648] | ChEMBL. | No reference |
Potency (functional) | 35.4813 uM | PubChem BioAssay. qHTS of TDP-43 Inhibitors. (Class of assay: confirmatory) | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.